Fed Completed Phase 1 Trials for Quetiapine (DB01224)

Also known as: FED

IndicationStatusPhase
DBCOND0052071 (Fed)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01603186Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed ConditionTreatment